Cecal Volvulus as a Rare Complication of Osimertinib Dosed at 160 Mg in Patients With EGFR-Mutant Non-Small Cell Lung Cancer
Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2020.00510
Full Text
Open PDFAbstract
Available in full text
Date
April 15, 2020
Authors
Publisher
Frontiers Media SA